ArticleIranian journal of public health2025
Hypoglycemia Incidence in Newborns Identified to Be at Risk, Data from a Tertiary Care Hospital in Turkey.
Article in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal hypoglycemia (NH) is one of the most prevalent neonatal problems. We aimed to describe frequency and patterns of NH in neonates at risk of hypoglycemia. Methods: In this single-center retrospective descriptive cross-sectional study, the incidence of hypoglycemia in newborns at risk of NH born at Mersin University Hospital between Jan 2017 and Jan 2023, was investigated. The blood glucose level being lower than 40 mg/dL was defined as NH. Results: Overall, 506 neonates at risk of hypoglycemia were included: 53 SGA infants (10.5%), 127 LGA infants (25.1%), 212 infants of diabetic mothers (41.9%), and 230 late preterm infants (45.5%). Hypoglycemia developed in 113 out of 506 at-risk newborns (22.3%). Symptomatic hypoglycemia developed in nine infants (1.8%), while asymptomatic hypoglycemia developed in 104 infants (20.5%). Recurrent hypoglycemia incidence was 4.2%. Severe hypoglycemia developed in 13 infants (2.6%). All symptomatic hypoglycemic infants and 8 asymptomatic hypoglycemic infants requiring IV glucose, 17 infants (17/506, 3.4%), were hospitalized in the NICU. The targeted blood glucose level was reached in 1 hour at the latest in all hypoglycemic infants. Conclusion: With the algorithm applied, we did not see recurrent hypoglycemia after the first day of life in risky newborns, and we reached the targeted glucose values in hypoglycemic newborns within the desired period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.